1. Market Research
  2. > Biotechnology
  3. > Biopharmaceutical Market Trends
  4. > Biopharmaceutical Analysis & Statistics, January 2015 (p20)

Biopharmaceutical Analysis & Statistics, January 2015 (p20)

24/7 Customer Support

Talk to Amrita

+33 9 73 87 19 47

Publishers

All regions

571-600 of about 1 900 reports

Purchase Reports From Reputable Market Research Publishers

Lyophilisation for Pharmaceuticals: Products and Services 2015-2025 & Future Prospects for Leading Companies

Lyophilisation for Pharmaceuticals: Products and Services 2015-2025 & Future Prospects for Leading Companies

  • € 2 249
  • Industry report
  • January 2015
  • by Visiongain

Report Details What are the commercial prospects for pharmaceutical freeze-drying? Visiongain’s brand new report gives you revenue predictions for the lyophilisation for pharmaceuticals market and its ...

  • Industries : Biopharmaceutical
  • Countries : World
Physician Views: The FDA gives a thumbs-up to the first potential US biosimilar, but what do oncologists think?

Physician Views: The FDA gives a thumbs-up to the first potential US biosimilar, but what do oncologists think?

  • € 492
  • Industry report
  • January 2015
  • by Firstword Pharma

Scope A significant step towards the realisation of biosimilar competition in the US market was taken last week when the FDA's Oncologic Drugs Advisory Committee (ODAC) voted unanimously to recommend approval ...

  • Industries : Biopharmaceutical, Biological Therapy, General Medicine and Specialty Medicine, Biotechnology, Therapy, Healthcare
Axial Spondyloarthritis Global Clinical Trials Review, H1, 2015

Axial Spondyloarthritis Global Clinical Trials Review, H1, 2015

  • € 2 000
  • Industry report
  • January 2015
  • by Global Data

Axial Spondyloarthritis Global Clinical Trials Review, H1, 2015 Summary GlobalData's clinical trial report, “Axial Spondyloarthritis Global Clinical Trials Review, H1, 2015" provides data on the Axial ...

  • Industries : Drug Discovery and Development, Pharmaceutical, Therapy
  • Countries : World
Foot and Mouth Disease (FMD) Vaccines Market (By Types: Conventional Vaccines and Emergency Vaccines, and By Applications: Cattle, Pigs, Sheep and Goats and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020

Foot and Mouth Disease (FMD) Vaccines Market (By Types: Conventional Vaccines and Emergency Vaccines, and By Applications: Cattle, Pigs, Sheep and Goats and Others) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020

  • € 3 836
  • Industry report
  • January 2015
  • by Transparency Market Research

Foot-and-mouth disease (FMD) is an infection caused by aphthovirus belonging to the family Picornaviridae. FMD is caused by seven different types of serotypes: O, A, C, Asia 1 and Southern African Territories ...

  • Industries : Biopharmaceutical, Drug and Medication
  • Countries : World
Biosimilars: European Payer Perspectives

Biosimilars: European Payer Perspectives

  • € 1 404
  • Industry report
  • January 2015
  • by Firstword Pharma

Cost is king when it comes to European biosimilars. One issue unites European healthcare payers: the need to provide biosimilars at the most affordable price in cash constrained health services. Biosimilars: ...

  • Industries : Biopharmaceutical
  • Countries : Europe
Key Pharma News 05 JANUARY 2015

Key Pharma News 05 JANUARY 2015

  • € 1 048
  • Industry report
  • January 2015
  • by Espicom Business Intelligence

Industry Trend Analysis - AbbVie HCV Approval Places Pressure On Gilead To Change Attitude To Drug Pricing Industry Trend Analysis - Diagnostics Gaining Wider Utility In The Pharmaceutical Market Industry ...

  • Industries : Drug and Medication, Biopharmaceutical
  • Countries : Japan
Cancer Vaccines: Technologies and Global Markets

Cancer Vaccines: Technologies and Global Markets

  • € 5 320
  • Industry report
  • January 2015
  • by BCC Research

REPORT HIGHLIGHTS The global market for cancer vaccines was about $4.5 billion in 2013. This market reached about $4.0 billion in 2014 and is expected to reach $4.3 billion in 2019, registering a compound ...

  • Industries : Biopharmaceutical, Drug and Medication, Pathology, Pharmaceutical
  • Countries : World
Biologic Therapeutic Drugs: Technologies and Global Markets

Biologic Therapeutic Drugs: Technologies and Global Markets

  • € 5 320
  • Industry report
  • January 2015
  • by BCC Research

REPORT HIGHLIGHTS The global biologics market totaled $200.6 billion in 2013 and is expected to grow to nearly $234 billion in 2014. The total market is expected to grow to $386.7 billion by the end of ...

  • Industries : Biopharmaceutical
  • Countries : World
World Enzyme-Linked Immunosorbent Assay (ELISA)  Industry

World Enzyme-Linked Immunosorbent Assay (ELISA) Industry

  • € 3 960
  • Industry report
  • January 2015
  • by Global Industry Analysts

This report analyzes the worldwide markets for Enzyme-Linked Immunosorbent Assay (ELISA) in US$ Thousands by the following Product Segments: ELISA Development Sets and Antibody Pairs, and ELISA Kits. The ...

  • Industries : Biopharmaceutical
  • Countries : World, Europe
Global Biosimilar Market Trends & Opportunities: 2015 Edition

Global Biosimilar Market Trends & Opportunities: 2015 Edition

  • € 640
  • Industry report
  • January 2015
  • by Daedal Research

Scope of the Report The report titled “Global Biosimilar Market: Trends & Opportunities (2015 Edition)” analyzes the global biologics market, with exhaustive discussion on demand of Biosimilars with ...

  • Industries : Biopharmaceutical, Biotechnology, Pharmaceutical, Drug and Medication
  • Countries : World, Europe
New Phase of Mab Biosimilar knocks the door Biosimilar Opportunities In Japan

New Phase of Mab Biosimilar knocks the door Biosimilar Opportunities In Japan

  • € 3 200
  • Industry report
  • January 2015
  • by MP Advisors

The launch of Remicade biosimilar in Dec-2014 in the Japan pharma market demonstrated its changing regulatory environment; it is faster than U.S. in adapting to biosimilar use. After nine years of continuous ...

  • Industries : Biopharmaceutical, Biotechnology
  • Countries : Japan
Antibody Drugs: Technologies and Global Markets

Antibody Drugs: Technologies and Global Markets

  • € 5 320
  • Industry report
  • January 2015
  • by BCC Research

REPORT HIGHLIGHTS The global market for antibody drugs was worth nearly $63.4 billion in 2013. This market is expected to grow at a compound annual growth rate (CAGR) of 12.2% between 2014 and 2019 resulting ...

  • Industries : Biopharmaceutical
  • Countries : World
Antibody Partnering Terms and Agreements

Antibody Partnering Terms and Agreements

  • € 2 396
  • Industry report
  • January 2015
  • by Currentpartnering

The Antibody Partnering Terms and Agreements report provides comprehensive understanding and unprecedented access to the antibody partnering deals and agreements entered into by the worlds leading healthcare ...

  • Industries : Biopharmaceutical
Infectious Vaccines Partnering Terms and Agreements

Infectious Vaccines Partnering Terms and Agreements

  • € 1 596
  • Industry report
  • January 2015
  • by Currentpartnering

The Infectious Vaccines Partnering Terms and Agreements report provides a detailed understanding and analysis of how and why companies enter infectious vaccines partnering deals. The majority of deals ...

  • Industries : Pharmaceutical, Biopharmaceutical, Drug and Medication, Biotechnology
  • Countries : United States, North America
PharmaPoint: Rheumatoid Arthritis - US Drug Forecast and Market Analysis to 2023

PharmaPoint: Rheumatoid Arthritis - US Drug Forecast and Market Analysis to 2023

  • € 3 996
  • Industry report
  • December 2014
  • by Global Data

PharmaPoint: Rheumatoid Arthritis - US Drug Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints. ...

  • Industries : Pharmaceutical
  • Countries : United States
PharmaPoint: Rheumatoid Arthritis - 5EU Drug Forecast and Market Analysis to 2023

PharmaPoint: Rheumatoid Arthritis - 5EU Drug Forecast and Market Analysis to 2023

  • € 5 596
  • Industry report
  • December 2014
  • by Global Data

PharmaPoint: Rheumatoid Arthritis - 5EU Drug Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints. ...

  • Industries : Biopharmaceutical, Pharmaceutical, Biotechnology
  • Countries : Europe
PharmaPoint: Rheumatoid Arthritis - Japan Drug Forecast and Market Analysis to 2023

PharmaPoint: Rheumatoid Arthritis - Japan Drug Forecast and Market Analysis to 2023

  • € 3 996
  • Industry report
  • December 2014
  • by Global Data

PharmaPoint: Rheumatoid Arthritis - Japan Drug Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints. ...

  • Industries : Pharmaceutical, Biopharmaceutical
  • Countries : Japan, Asia
PharmaPoint: Rheumatoid Arthritis - Australia Drug Forecast and Market Analysis to 2023

PharmaPoint: Rheumatoid Arthritis - Australia Drug Forecast and Market Analysis to 2023

  • € 3 996
  • Industry report
  • December 2014
  • by Global Data

PharmaPoint: Rheumatoid Arthritis - Australia Drug Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the ...

  • Industries : Pharmaceutical, Biopharmaceutical
  • Countries : Australia, Oceania
PharmaPoint: Rheumatoid Arthritis - China Drug Forecast and Market Analysis to 2023

PharmaPoint: Rheumatoid Arthritis - China Drug Forecast and Market Analysis to 2023

  • € 3 996
  • Industry report
  • December 2014
  • by Global Data

PharmaPoint: Rheumatoid Arthritis - China Drug Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints. ...

  • Industries : Pharmaceutical, Biopharmaceutical
  • Countries : China, Asia
PharmaPoint: Rheumatoid Arthritis - India Drug Forecast and Market Analysis to 2023

PharmaPoint: Rheumatoid Arthritis - India Drug Forecast and Market Analysis to 2023

  • € 3 996
  • Industry report
  • December 2014
  • by Global Data

PharmaPoint: Rheumatoid Arthritis - India Drug Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints. ...

  • Industries : Pharmaceutical, Biopharmaceutical
  • Countries : India, Asia
PharmaPoint: Rheumatoid Arthritis - Global Drug Forecast and Market Analysis to 2023

PharmaPoint: Rheumatoid Arthritis - Global Drug Forecast and Market Analysis to 2023

  • € 8 796
  • Industry report
  • December 2014
  • by Global Data

PharmaPoint: Rheumatoid Arthritis - Global Drug Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints ...

  • Industries : Hospitality, Hospitality, Tourism, Tourism, Biopharmaceutical, Biotechnology, Pharmaceutical
  • Countries : World, Europe
Humira (adalimumab) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

Humira (adalimumab) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

  • € 2 796
  • Industry report
  • December 2014
  • by Global Data

Humira (adalimumab) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints. ...

  • Industries : Pharmaceutical, Pathology, Biopharmaceutical
  • Countries : World
Remicade (infliximab) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

Remicade (infliximab) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

  • € 2 796
  • Industry report
  • December 2014
  • by Global Data

Remicade (infliximab) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints. ...

  • Industries : Pharmaceutical, Pathology
  • Countries : World
Simponi (golimumab) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

Simponi (golimumab) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

  • € 2 796
  • Industry report
  • December 2014
  • by Global Data

Simponi (golimumab) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints. ...

  • Industries : Pharmaceutical, Pathology
  • Countries : World
Cimzia (certolizumab pegol) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

Cimzia (certolizumab pegol) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

  • € 2 796
  • Industry report
  • December 2014
  • by Global Data

Cimzia (certolizumab pegol) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the ...

  • Industries : Pharmaceutical
  • Countries : World
Actemra/ RoActemra (tocilizumab) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

Actemra/ RoActemra (tocilizumab) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

  • € 2 796
  • Industry report
  • December 2014
  • by Global Data

Actemra/ RoActemra (tocilizumab) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity ...

  • Industries : Pharmaceutical, Pathology
Biosimilars (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

Biosimilars (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

  • € 2 796
  • Industry report
  • December 2014
  • by Global Data

Biosimilars (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints . It affects ...

  • Industries : Biopharmaceutical, Biotechnology, Pharmaceutical
  • Countries : World
Denosumab (Prolia) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

Denosumab (Prolia) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023

  • € 2 796
  • Industry report
  • December 2014
  • by Global Data

Denosumab (Prolia) (Rheumatoid Arthritis) - Forecast and Market Analysis to 2023 Summary Rheumatoid arthritis (RA) is a chronic autoimmune disease which causes inflammation and deformity of the joints ...

  • Industries : Pharmaceutical, Biopharmaceutical
Rheumatoid Arthritis Market to 2020 - A Crowded Market Characterized by Modest Growth

Rheumatoid Arthritis Market to 2020 - A Crowded Market Characterized by Modest Growth

  • € 3 996
  • Industry report
  • December 2014
  • by GBI Research

Rheumatoid Arthritis Market to 2020 - A Crowded Market Characterized by Modest Growth Summary Increasingly Crowded Market for Second-Line Therapies Improving Treatment Options for Moderate-to-Severe Rheumatoid ...

  • Industries : Pharmaceutical, Pathology
  • Countries : World
Pollen Allergy - Pipeline Review, H2 2014

Pollen Allergy - Pipeline Review, H2 2014

  • € 1 600
  • Industry report
  • December 2014
  • by Global Markets Direct

Pollen Allergy - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Pollen Allergy - Pipeline Review, H2 2014’, provides an overview of the Pollen Allergy’s therapeutic pipeline. This report ...

  • Industries : Drug and Medication, Biopharmaceutical, Research and Development, Pharmaceutical
  • Countries : Japan, World
About 6 700 reports

Download Unlimited Documents from Trusted Public Sources

Vaccine Statistics in the UK, Quarterly Update

  • June 2015
    13 pages
  • Vaccine  

    Hepatitis B  

  • United Kingdom  

    Europe  

View report >

Enzyme Supply

June 2015

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.